MedPath
TGA Approval

BENLYSTA belimumab 400 mg powder for injection vial (173078)

173078

BENLYSTA belimumab 400 mg powder for injection vial

GlaxoSmithKline Australia Pty Ltd

October 18, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/9cc2c577e04fda0e53eeae12e240e0b6.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/677c40a736a604c7072e0284c10fac69.pdf

Active Ingredients

Belimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.